GRAPHITE BIO INC's ticker is GRPH and the CUSIP is 38870X104. A total of 60 filers reported holding GRAPHITE BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | -3.2% | 36,585 | +0.8% | 0.00% | – |
| Q2 2023 | $94 | -90.6% | 36,300 | +12417.2% | 0.00% | – |
| Q2 2022 | $1,000 | -99.2% | 290 | -98.8% | 0.00% | – |
| Q1 2022 | $123,000 | +68.5% | 24,040 | +311.6% | 0.00% | – |
| Q4 2021 | $73,000 | -21.5% | 5,840 | +2.5% | 0.00% | – |
| Q3 2021 | $93,000 | – | 5,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 8,459,314 | $20,979,099 | 6.42% |
| OUP Management Co., LLC | 406,308 | $1,007,644 | 2.27% |
| Prosight Management, LP | 1,337,826 | $3,317,808 | 1.05% |
| EcoR1 Capital, LLC | 8,538,446 | $21,175,346 | 0.71% |
| TANG CAPITAL MANAGEMENT LLC | 2,016,626 | $5,001,232 | 0.71% |
| Privium Fund Management (UK) Ltd | 191,244 | $453,248 | 0.36% |
| Newtyn Management, LLC | 542,637 | $1,345,740 | 0.33% |
| Aldebaran Capital, LLC | 130,000 | $322,400 | 0.33% |
| Acuitas Investments, LLC | 195,762 | $485,490 | 0.28% |
| CHI Advisors LLC | 230,938 | $572,726 | 0.23% |